Mountain View, CA – According to filings with the U.S. Securities and Exchange Commission, AliveCor is raising $70,000,000.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, John Maley played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AliveCor

AliveCor, Inc. is pioneering the creation of FDA-cleared machine learning techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared KardiaMobile is the most clinically validated mobile EKG solution on the market. It is recommended by leading cardiologists and used by people worldwide for accurate EKG recordings. KardiaMobile, and KardiaBand, when paired with the Kardia app provide instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG.

To learn more about AliveCor, visit http://www.alivecor.com/

Contact:
John Maley, Chief Financial Officer
855-338-8800
jmaley@alivecor.com
https://www.linkedin.com/in/john-maley-8367231/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved